Risk Factors for Weight Gain Following Switch to Integrase Inhibitor–Based Antiretroviral Therapy is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 196 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: K23AI110532
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068634
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068636
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI106701
National Institute on Aging
Grant: R01 AG054366
NIAID NIH HHS
Grant: U01 AI068634
NIAID NIH HHS
Grant: UM1 AI069471
NIDDK NIH HHS
Grant: P30 DK048520
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
National Institutes of Health
Grant: 1K23AI110532-01A1
Inflammation, Fibrosis and End-Organ Disease in HIV-Infected Adults
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 5R01AG054366-03
Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
FWCI
28.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals